Story · Medicine & Biotech

Aspirin does not reduce risks for major CV events vs. usual care in CKD

1 outlet · first reported by Healio 14d ago

Coverage, in order

  1. 14d ago
    Healio indie
    Aspirin does not reduce risks for major CV events vs. usual care in CKD

    DENVER — Low-dose aspirin did not significantly reduce risks for major CV events vs. usual care among patients with chronic kidney disease, according to data presented at ASN Kidney Week. “We’re not in a place where we should be offering aspirin for primary prevention at this stage,” Hugh…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.